Rimonabant
In Stock•Starting at $8 for 1 mg•Purity ≥ 99%
| CAS No. | 168273-06-1 |
|---|---|
| MDL No. | MFCD04034714 |
| MF | C22H21Cl3N4O |
| MW | 463.80 |
| InChI Key | JZCPYUJPEARBJL-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $8 | In Stock | |
| 10 mg | 99% | $9 | In Stock | |
| 50 mg | 99% | $19 | In Stock | |
| 100 mg | 99% | $23 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Rimonabant is a carbohydrazide formed by the formal condensation of the carboxy group of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. It is a potent and selective CB1 receptor antagonist and inverse agonist at micromolar concentrations. As the first selective CB1 antagonist/inverse agonist in clinical use, it was used to treat obesity and metabolic disorders but was withdrawn due to CNS adverse effects, including depression and suicidal ideation. It functions as an anti-obesity agent, CB1 receptor antagonist, and appetite depressant. It belongs to the classes of pyrazoles, dichlorobenzenes, carbohydrazides, amidopiperidines, and monochlorobenzenes.
| CAS No. | 168273-06-1 |
|---|---|
| Product Name | Rimonabant |
Biological Targets
CNR1
Associated Conditions
alcohol drinking·obesity·Hepatic steatosis·prediabetes syndrome·Prader-Willi syndrome·
* The information provided here is compiled from public sources and is for reference only.
